Phase 1 study and Investigator Initiated Trial evaluating KL003 for patients with beta thalassemia demonstrated an encouraging efficacy signal ...
FDA Project Team supports the company’s proposed Phase 3 trial strategy, including overall trial design, target patient population, treatment ...
Make your project unique with custom icon design.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback